Multimodal Assessment of Cognitive Impairment in Alzheimer Patients

Status: Recruiting
Location: See location...
Intervention Type: Device, Behavioral, Biological
Study Type: Observational
SUMMARY

The goal of this study is to learn more about the changes in the brains of patients with cognitive impairment (MCI) and Alzheimer's Disease (AD). The main questions the study aims to answer are: 1. What findings can be used to earlier detect patients that will develop Alzheimers? 2. Which differences are seen between healthy and cognitively impaired patients? 3. Which differences are seen between patients with Alzheimers disease? Participants will undergo: * Cognitive tests * Magnetic resonance imaging (MRI) * Electroencephalography (EEG) * Blood sample collection * Fecal sample collection * A randomized group will undergo polysomnography analysis.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: t
View:

• MCI and AD according to relevant ICD-criterias.

• Control cohort is age and gender matched with other cohorts.

Locations
Other Locations
Norway
Norwegian University of Sciene and Technology / Norges teknisk-naturvitenskapelige universitet (NTNU)
RECRUITING
Trondheim
Contact Information
Primary
Axel Sandvig, Prof., MD, PhD
axel.sandvig@ntnu.no
72 57 56 20
Time Frame
Start Date: 2024-07-01
Estimated Completion Date: 2030-12-29
Participants
Target number of participants: 60
Treatments
MCI
Recruitment according to relevant clinical assessment and ICD-criterias.
Mild AD
Recruitment according to relevant clinical assessment and ICD-criterias.
Control
Equivalent number of research participants as in the MCI and mild AD group.
Related Therapeutic Areas
Sponsors
Leads: Norwegian University of Science and Technology

This content was sourced from clinicaltrials.gov